Injection Pen Market Anticipated to Reach USD 100.01 Billion by 2034, Expanding at a CAGR of 7.9%

Market Overview:

The injection pen market size was valued at USD 46.97 billion in 2024. It is projected to grow to USD 100.01 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2025 to 2034.

Market Definition:

An injection pen is a widely used device for administering medication, providing a more convenient and easy method. These pens are more popular than vials and syringes as they allow for quicker administration of medication. Injection pens come in two varieties: disposables and reusables, both used for administering medications. Disposable pens come with insulin cartridges that are pre-filled and thrown away once used.

Growth Drivers and Opportunities:

The growing incidence of long-lasting illnesses such as cancer, diabetes, rheumatoid arthritis, and multiple sclerosis has greatly raised the need for injectable drugs.
The increasing number of older adults is crucial in creating a need for injection pens, as seniors are at a higher risk of developing multiple chronic health issues that necessitate consistent medication.

Key Players:

With so many businesses involved, the market is projected to become more competitive as it continues to grow. Here is the list of the leading companies operating in the injection pen market:

BD
Eli Lilly
Ypsomed AG
Biocon
Pfizer Inc.
Novartis AG
Novo Nordisk A/S
Sanofi
Owen Mumford Ltd.
Merck KGaA

Segmentation Overview:

Injection Pen Market, Product Outlook (Revenue – USD Billion, 2020-2034)

Disposable
Reusable

Injection Pen Market, Applications Outlook (Revenue – USD Billion, 2020-2034)

Diabetes
Anaphylaxis
Osteoporosis
Growth Hormone Deficiency
Arthritis
Others

Injection Pen Market, End Use Outlook (Revenue – USD Billion, 2020-2034)

Hospital
Clinics
Home Care Settings

The injection pen market is mainly segmented based on the product, application, end use, and region. Based on the product analysis, the reusable segment held the larger market share in 2024 because of its affordability, eco-friendliness, and ease of use. The capacity to customize dosages using refillable pens, in addition to their sturdy construction and ability to work with various medications, increases patient compliance and contentment.

Furthermore, according to the end use analysis, during the projection period, the clinics segment is anticipated to witness the highest CAGR due to the growing trend towards outpatient care and the rise in specialized clinics providing treatment for chronic illnesses.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/injection-pen-market

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Injection Pen Market Insights
4.1. Injection Pen Market – Market Snapshot
4.2. Injection Pen Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising prevalence of chronic diseases is driving the market growth
4.2.1.2. Rising Geriatric Population propels the market
4.2.2. Restraints and Challenges
4.2.2.1. Complex regulatory environment is hindering the injection pen market growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Injection Pen Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

The injection pen market growth is driven by the increasing prevalence of chronic diseases and the rising demand for self-administration devices. The industry outlook indicates a robust expansion fueled by technological advancements that enhance user experience and safety.

Injection Pen Industry Developments:

Cross-Industry Recycling Initiative (September 2023)
Sanofi, in collaboration with Eli Lilly, Novo Nordisk, and Merck KGaA, launched the first-ever cross-industry recycling initiative for injection pens. The program debuted in Denmark, leveraging the country’s robust recycling infrastructure. Together, the companies distribute approximately 6 million injection pens annually, with a goal to recycle 25% of them in the first year, reducing 25 tons of plastic waste.
BIOCORP and Merck Collaboration (September 2021)
BIOCORP partnered with Merck to create a specialized version of the Mallya device, designed for monitoring adherence in human growth hormone (HGH) therapy. The Mallya is a Bluetooth-enabled clip for pen injectors that records injection dosage and timing, transmitting data in real time to companion software. This innovation enhances treatment tracking and supports improved patient outcomes.